Figure 7 | Scientific Reports

Figure 7

From: Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)

Figure 7

Ex vivo analysis of immune cell infiltration in tumor post treatment with anti-HER2/neu antibody and TLR7/8 agonists (A) Percentage of CD49b+/CD3- NK cells in tumor, *P < 0.05 (B) Percentage of CD69+ NK cells in tumor (C) Percentage of NKG2D+ NK cells in tumor, *P < 0.05 (D) Percentage of CD45+ ‘non-tumor’ cells in tumor, *P < 0.05. All statistical analysis is based on ordinary one-way ANOVA with multiple comparisons.

Back to article page